{"product_id":"marimedinc-business-model-canvas","title":"MariMed Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMariMed Business Model Canvas: Actionable Blueprint for Investors \u0026amp; Founders\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock the full strategic blueprint behind MariMed’s business model—this concise Business Model Canvas exposes its value propositions, customer segments, key partners, and revenue levers to reveal how the company scales and sustains competitive advantage; ideal for investors, consultants, and founders seeking actionable, ready-to-use insights—download the complete Word and Excel files to deep-dive, benchmark, and apply the strategy today.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMulti-State Retail Partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMariMed partners with independent dispensaries to secure premium shelf space for proprietary brands like Betty Eddies and Bubby Baked, driving retail reach in 12 states where MariMed lacks storefronts; wholesale sales to these partners accounted for about $34.5M (22% of 2024 revenue) and grew 18% YoY. These alliances ensure steady supply, reduce go-to-market costs, and lock multi-year contracts that improve market share and predictability for third-party vendors.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Real Estate Developers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMariMed partners with specialized REITs and developers to secure and build cultivation and processing sites, enabling rapid scale—26 new facility leases secured in 2024 cut capex needs by an estimated $42M through sale-leaseback structures.\u003c\/p\u003e\n\u003cp\u003eThese partnerships solve the primary barrier—compliant, zoned property—by delivering strategically located sites across 8 states, reducing site-acquisition lead time from 14 months to under 6 months on average.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory and Legal Consultants\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMariMed keeps retainer relationships with state-focused cannabis law firms and lobbyists to navigate 30+ state regulatory regimes; in 2024 these services helped secure 6 new cultivation\/retail licenses and avoided $4.2M in potential fines via proactive compliance reviews.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTechnology and Lab Testing Partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMariMed uses state-certified third-party labs for safety and potency testing to meet regulations, averaging 100% batch compliance in 2024 across markets where it operates.\u003c\/p\u003e\n\u003cp\u003eThey license seed-to-sale tracking software that syncs with state systems (Metrc, etc.), supporting traceability for ~1.5 million packaged units shipped in 2024 and preserving data integrity.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eThird-party labs: regulatory compliance, 100% batch pass rate (2024)\u003c\/li\u003e\n\u003cli\u003eSeed-to-sale software: Metrc integration, 1.5M units tracked (2024)\u003c\/li\u003e\n\u003cli\u003eOutcome: full product transparency, audit-ready data trails\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBrand Licensing and IP Collaborators\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMariMed uses licensing deals to import third-party IP and export its own brands, enabling market entry without full vertical build-out; by 2024 it reported brand-licensing revenue of $18.6M, boosting international footprint in 4 countries.\u003c\/p\u003e\n\u003cp\u003eAgreements include shared marketing budgets (often 10–20% of net sales) and ISO-like standardized production protocols to keep product consistency and reduce recall risk.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 licensing revenue: $18.6M\u003c\/li\u003e\n\u003cli\u003eGeographic reach via partners: 4 countries (2024)\u003c\/li\u003e\n\u003cli\u003eMarketing support: typically 10–20% of net sales\u003c\/li\u003e\n\u003cli\u003eStandardized protocols to lower recall risk\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMariMed partners drive $53.1M revenue, 1.5M units, 100% batch pass, faster site deals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMariMed’s key partners—independent dispensaries, REITs\/developers, state law firms, third-party labs, seed-to-sale vendors, and licensees—drove $34.5M wholesale (22% of 2024 rev), $18.6M licensing revenue, 1.5M units tracked, 26 facility leases, 100% batch pass rate, and reduced site-acquisition time from 14 to 6 months.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eWholesale revenue\u003c\/td\u003e\n\u003ctd\u003e$34.5M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLicensing revenue\u003c\/td\u003e\n\u003ctd\u003e$18.6M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUnits tracked\u003c\/td\u003e\n\u003ctd\u003e1.5M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFacility leases\u003c\/td\u003e\n\u003ctd\u003e26\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBatch pass rate\u003c\/td\u003e\n\u003ctd\u003e100%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAcq lead time\u003c\/td\u003e\n\u003ctd\u003e6 months\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise, pre-written Business Model Canvas for MariMed outlining customer segments, channels, value propositions, revenue streams, key activities, partners, resources, cost structure, and governance—mapped to real-world operations and strategic plans. Ideal for presentations and investor discussions, it includes SWOT-linked insights and competitive advantages to support decision-making and validation using company data.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses MariMed’s strategy into a digestible one-page Business Model Canvas, saving hours of structuring while providing an editable, shareable snapshot for quick internal review, boardroom presentations, or side-by-side comparisons.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCultivation and Harvest Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMariMed operates large-scale indoor and greenhouse cultivation producing high-quality cannabis flower, running ~150,000 sq ft of canopy across facilities and targeting 800–1,000 lbs monthly in 2025; they control HVAC, CO2, light cycles, and nutrient regimens to maximize yield and tailor cannabinoid profiles via selective genetics. Efficient cultivation underpins their seed-to-sale model, supporting processing and retail with ~70% of input supply internally sourced.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProduct Manufacturing and Infusion\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe company runs GMP-like processing facilities that convert raw cannabis into oils, concentrates, and infused products, producing over 3.2 million units in 2024 and generating roughly $145M in infused-product revenue that year; award-winning edibles and topicals use precise dosing, culinary R\u0026amp;D, and batch testing to hit ±5% potency targets; manufacturing emphasizes consistency and safety—third-party lab pass rates exceeded 99% in 2024—to maintain consumer trust.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRetail Dispensary Operations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMariMed operates Panacea Wellness and partner brands, running daily retail tasks—inventory tracking, POS sales, and staff-led product curation—for medical and adult-use customers.\u003c\/p\u003e\n\u003cp\u003eIn 2025 MariMed’s retail segment targets average basket growth of 12% and a repeat-customer rate above 40%, using merch, staff training, and data-driven promotions to boost revenue per visit.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBrand Development and Marketing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eA core activity is creating and positioning MariMed house brands to stand out: in 2024 MariMed reported $160.5M revenue and increased branded SKU mix to 62%, driving higher margins and retailer uptake.\u003c\/p\u003e\n\u003cp\u003eWork includes market research, packaging design, and targeted ad campaigns (digital spend rose 18% in 2024) to build premium equity with wholesalers and consumers.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHouse brands: 62% of SKUs (2024)\u003c\/li\u003e\n\u003cli\u003eRevenue: $160.5M (2024)\u003c\/li\u003e\n\u003cli\u003eAd spend growth: +18% YoY (2024)\u003c\/li\u003e\n\u003cli\u003eFocus: packaging, market research, targeted ads\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory Compliance and Licensing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThe company spends roughly 6–8% of annual SG\u0026amp;A on compliance, tracking state law shifts across 15 US markets and conducting quarterly audits of security, waste disposal, and staff certification to protect 42 state licenses.\u003c\/p\u003e\n\u003cp\u003eProactive compliance cut regulatory fines by 72% from 2019–2024 and limits operational shutdown risk, preserving estimated annual revenue of $45–60M tied to licensed facilities.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e6–8% of SG\u0026amp;A on compliance\u003c\/li\u003e\n\u003cli\u003eCoverage: 15 US markets, 42 state licenses\u003c\/li\u003e\n\u003cli\u003eQuarterly audits: security, waste, training\u003c\/li\u003e\n\u003cli\u003eFines down 72% (2019–2024)\u003c\/li\u003e\n\u003cli\u003e$45–60M annual revenue protected\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMariMed scales 150k sq ft canopy, $160.5M revenue \u0026amp; 3.2M units with 62% branded SKUs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMariMed runs 150,000 sq ft canopy aiming 800–1,000 lbs\/month (2025), GMP-like processing producing 3.2M+ units (2024), branded SKUs 62% driving $160.5M revenue (2024), compliance 6–8% SG\u0026amp;A covering 15 markets\/42 licenses; targets 12% basket growth and \u0026gt;40% repeat rate (2025).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eCanopy\u003c\/td\u003e\n\u003ctd\u003e150,000 sq ft\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eYield target\u003c\/td\u003e\n\u003ctd\u003e800–1,000 lbs\/mo (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUnits\u003c\/td\u003e\n\u003ctd\u003e3.2M+ (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003e$160.5M (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBranded SKUs\u003c\/td\u003e\n\u003ctd\u003e62% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCompliance spend\u003c\/td\u003e\n\u003ctd\u003e6–8% SG\u0026amp;A\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMarkets\/Licenses\u003c\/td\u003e\n\u003ctd\u003e15 markets \/ 42 licenses\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRetail targets\u003c\/td\u003e\n\u003ctd\u003e+12% basket, \u0026gt;40% repeat (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Version Awaits\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe document you're previewing is the actual MariMed Business Model Canvas—not a mockup—and reflects the exact content and layout you'll receive after purchase.\u003c\/p\u003e\n\u003cp\u003eWhen you complete your order, you'll be granted the same full deliverable, ready-to-edit in Word and Excel, with no hidden sections or altered formatting.\u003c\/p\u003e\n\u003cp\u003eWe provide transparency: what you see is the final file, instantly downloadable and usable for presentations, planning, and implementation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56749161546105,"sku":"marimedinc-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/marimedinc-business-model-canvas.png?v=1772213385","url":"https:\/\/growthsharematrix.com\/products\/marimedinc-business-model-canvas","provider":"Growth Share Matrix","version":"1.0","type":"link"}